$Dual specific CD19/CD22-targeted chimeric antigen receptor T-cell therapy for refractory diffuse large B-cell lymphoma: A case report$

Dual specific CD19/CD22-targeted chimeric antigen receptor T-cell therapy for refractory diffuse large B-cell lymphoma: A case report

Clinical trials of chimeric antigen receptors (CARs) targeting CD19 have produced impressive results in hematological malignancies, including diffuse large B-cell lymphoma (DLBCL). However, a notable number of patients with DLBCL fail to achieve remission after CD19 CAR T-cell therapy and may theref...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2020-10, Vol.20 (4), p.21
Hauptverfasser:	Huang, Chen, Zhang, Hui-Chao, Ho, Jin-Yuan, Liu, Rui-Xia, Wang, Lin, Kuang, Na, Zheng, Mei-Rong, Liu, Li-Hong, Li, Jian-Qiang
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Antibodies Antigens B cells Biopsy Carboplatin Care and treatment Case reports Chemotherapy Clinical trials Ethylenediaminetetraacetic acid Immunotherapy Leukemia Lymphatic system Lymphocytes Lymphoma Medical imaging Non-Hodgkin's lymphomas Patients Radiation therapy Stem cells T cells Transplants & implants Vincristine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!